3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
12
Glioblastoma
11
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
8
Oropharyngeal Neoplasms
7
Lung Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Burkitt Lymphoma
5
Astrocytoma
5
Urinary Bladder Neoplasms
4
Carcinoma
4
Adenocarcinoma of Lung
4
Sarcoma
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hodgkin Disease
3
Gliosarcoma
3
Glioma
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Rhabdomyosarcoma, Alveolar
2
Prostate Adenocarcinoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
Cyclophosphamide
9
fludarabine
7
Dexamethasone
7
pomalidomide
6
Rituximab
6
pembrolizumab
5
selinexor
4
obinutuzumab
4
glofitamab
4
Lenalidomide
4
daratumumab
3
belantamab mafodotin
3
Temozolomide
3
Gemcitabine
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
fludarabine phosphate
2
enzalutamide
2
cemiplimab
2
carfilzomib
2
abemaciclib
2
PF06821497
2
Mesna
2
Lisaftoclax
2
Injections
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Radiotherapy
×
30 days
×
Clear all
No trials found.